ACRO Biomedical Co., Ltd. (TPEX:6748)

ACRO Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,704	1,564	2,409	1,024	939	-
Market Cap Growth	134.04%	-35.07%	135.16%	9.09%	-	-
Enterprise Value	3,264	1,051	2,150	922	837	-
Last Close Price	60.50	25.28	38.94	19.69	24.61	-
PS Ratio	101.47	35.36	47.18	37.07	43.02	-
PB Ratio	6.37	2.50	3.51	2.71	7.22	-
P/TBV Ratio	6.44	2.52	3.56	2.76	7.69	-
EV/Sales Ratio	89.41	23.75	42.11	33.37	38.33	-
Debt / Equity Ratio	0.02	0.03	0.03	0.03	0.10	0.08
Asset Turnover	0.06	0.06	0.09	0.10	0.12	0.10
Inventory Turnover	1.82	1.79	1.09	1.05	0.52	0.66
Quick Ratio	27.49	27.58	39.66	25.82	6.11	8.77
Current Ratio	28.89	28.68	41.04	27.80	9.01	10.98
Return on Equity (ROE)	-12.86%	-9.46%	-7.78%	-23.94%	-32.92%	-32.92%
Return on Assets (ROA)	-7.76%	-5.89%	-5.46%	-14.27%	-18.87%	-19.88%
Return on Capital Employed (ROCE)	-13.60%	-10.20%	-6.90%	-16.30%	-38.30%	-29.50%
Earnings Yield	-2.16%	-3.97%	-1.72%	-5.94%	-5.41%	-
FCF Yield	-1.87%	-4.73%	-2.88%	-4.83%	-5.13%	-
Buyback Yield / Dilution	-6.10%	-16.17%	-11.65%	-32.92%	-17.13%	-20.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.